Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial.

Colhoun HM, Lincoff AM, Ryan D, Lingvay I, Kahn SE, Hovingh GK, Hardt-Lindberg S, Oral TK, Weeke PE, Linder M, Linhart A, Burguera B, van Beek AP, Saraiva JFK, Arbel Y, Emerson SS, Plutzky J, Deanfield J

Open source

DOI: 10.1093/eurheartj/ehag524
Published: 2026 Sep 23
Container: European heart journal
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/eurheartj/ehag524,
  title = {Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial.},
  author = {Colhoun HM and Lincoff AM and Ryan D and Lingvay I and Kahn SE and Hovingh GK and Hardt-Lindberg S and Oral TK and Weeke PE and Linder M and Linhart A and Burguera B and van Beek AP and Saraiva JFK and Arbel Y and Emerson SS and Plutzky J and Deanfield J},
  year = {2026},
  journal = {European heart journal},
  doi = {10.1093/eurheartj/ehag524},
  url = {https://doi.org/10.1093/eurheartj/ehag524}
}

RIS

TY  - JOUR
TI  - Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial.
AU  - Colhoun HM
AU  - Lincoff AM
AU  - Ryan D
AU  - Lingvay I
AU  - Kahn SE
AU  - Hovingh GK
AU  - Hardt-Lindberg S
AU  - Oral TK
AU  - Weeke PE
AU  - Linder M
AU  - Linhart A
AU  - Burguera B
AU  - van Beek AP
AU  - Saraiva JFK
AU  - Arbel Y
AU  - Emerson SS
AU  - Plutzky J
AU  - Deanfield J
PY  - 2026
JO  - European heart journal
DO  - 10.1093/eurheartj/ehag524
UR  - https://doi.org/10.1093/eurheartj/ehag524
ER  -

APA

HM, C., AM, L., D, R., I, L., SE, K., GK, H., S, H., TK, O., PE, W., M, L., A, L., B, B., AP, V. B., JFK, S., Y, A., SS, E., J, P., & J, D. (2026). Semaglutide and cardiovascular risk reduction: a mediation analysis of the SELECT trial.. European heart journal. https://doi.org/10.1093/eurheartj/ehag524

Source records

pubmed · retrieved 2026-09-26T04:33:02.391Z